Information For Patients | Genetic Cancer Tests | RGCC Group

Download our app Order a test

We are leading experts in the field of cancer genetics and chemosensitivity tests. We have been working with GPs and doctors all over the world since 2004 to provide the most up-to-date cancer detection and chemosensitivity tests available.

We aim to detect any potential early signs of cancer, monitor any existing cancers and produce a personalised profile of chemotherapy drugs and natural treatments that could benefit individual patients.

We can work directly with you or your doctor to carry out a liquid biopsy. We will analyse your blood samples and identify information that can be potentially useful for identifying and diagnosing certain types of cancer.

In addition to being a diagnostic tool, liquid biopsy tests can be useful in monitoring the progress of the disease. The results of our tests can provide doctors with additional insights to support the development of personalised patient treatment plans.

All of our tests are carried out at our ISO-accredited laboratories, which are equipped with the latest technology and specialised software for data analysis.

Patient info leaflet

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

Need help?

Can brain tumours also be tested with a blood sample?

No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample.

Is it possible to measure circulating tumour cells (CTC) in patients with lymphoma or leukaemia?

Yes, patients with lymphoma or leukaemia can use an RGCC test to measure the number of circulating tumour cells (CTC) they have.

Which test is the most comprehensive test?

The most comprehensive test is the “Onconomics Plus” test. This provides information on the sensitivity or resistance of the patient’s tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

How do online consultations work?

Our global team of cancer experts are on hand to provide support and advice to both patients and fellow RGCC clinicians. It’s very simple:

Head to the Cancer A-Z app and navigate to the “Consultations” area.
You will be asked to complete a short online questionnaire to give us more information about your current concerns or requirements.
You will browse a shortlist of RGCC Network clinicians who can best help your needs.
Select your chosen consultant and then select your preferred consultation date and time using our interactive calendar.
You will receive a notification in our secure messaging area to confirm your appointment. If your consultant requires additional information before your meeting, they will contact you via the secure messaging area.

Do online consultations take place via Zoom, Skype or another method?

Your chosen clinician will be in touch to make the arrangements and choose the most convenient method.

Didn't find an answer to your question? Contact us directly.

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.